SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000893220-00-001154
Filing Date
2000-10-18
Accepted
2000-10-18 00:00:00
Documents
8
Period of Report
2000-10-10
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K CEPHALON FOR 10/10/2000 w41190e8-k.txt 8-K 9080
2 AGREEMENT AND PLAN OF MERGER w41190ex2-1.txt EX-2.1 142311
3 PROXY STATEMENT PROSPECTUS w41190ex20-1.txt EX-20.1 231885
4 ANESTA'S AUDITED YEAR END FINANCIAL STATEMENTS w41190ex20-2.txt EX-20.2 60135
5 ANESTA'S UNAUDITED FINANCIAL STATEMENTS w41190ex20-3.txt EX-20.3 23832
6 PRO FORMA FINANCIAL STATEMENTS w41190ex20-4.txt EX-20.4 29235
7 CONSENT OF PRICEWATERHOUSECOOPERS w41190ex23-1.txt EX-23.1 770
8 PRESS RELEASE DATED 10/10/2000 w41190ex99-1.txt EX-99.1 4425
  Complete submission text file 0000893220-00-001154.txt   504228
Mailing Address 145 BRANDYWINE PARKWAY WEST CHESTER PA 19380
Business Address 145 BRANDYWINE PKWY WEST CHESTER PA 19380 6103440200
CEPHALON INC (Filer) CIK: 0000873364 (see all company filings)

IRS No.: 232484489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19119 | Film No.: 742169
SIC: 2834 Pharmaceutical Preparations